Lingling Shu
Impact in
-
- Cancer-related molecular mechanisms research
-
- Liver physiology and pathology
Papers in
-
- Peroxisome Proliferator-Activated Receptors 6
- Protein Degradation and Inhibitors 2
- Immunology 12
- Immune Cell Function and Interaction 6
- Immune cells in cancer 4
- Co-authors
- Aimin Xu (9 shared papers)Ruby L.C. Hoo (8 shared papers)Karen S.L. Lam (3 shared papers)Xiaoping Wu (3 shared papers)Boya Liao (3 shared papers)Yong Pan (2 shared papers)Weida Wang (5 shared papers)Paul M. Vanhoutte (2 shared papers)
In The Last Decade
Lingling Shu
33 papers receiving 591 citations
Peers
Comparison fields: 5 of 86
- Cancer Research 125
- Hepatology 47
- Neurology 46
- Immunology 87
- Molecular Biology 274
Countries citing papers authored by Lingling Shu
This map shows the geographic impact of Lingling Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingling Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingling Shu more than expected).
Fields of papers citing papers by Lingling Shu
This network shows the impact of papers produced by Lingling Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingling Shu. The network helps show where Lingling Shu may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingling Shu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 83 | |
| 2 | 2020 | 79 | |
| 3 | 2021 | 77 | |
| 4 | 2020 | 75 | |
| 5 | 2015 | 45 | |
| 6 | 2021 | 31 | |
| 7 | 2021 | 29 | |
| 8 | 2017 | 19 | |
| 9 | 2021 | 18 | |
| 10 | 2020 | 15 | |
| 11 | 2022 | 14 | |
| 12 | 2020 | 13 | |
| 13 | 2024 | 13 | |
| 14 | 2018 | 13 | |
| 15 | 2023 | 12 | |
| 16 | 2021 | 12 | |
| 17 | 2023 | 6 | |
| 18 | 2020 | 6 | |
| 19 | 2021 | 5 | |
| 20 | 2024 | 5 |
About Lingling Shu
Lingling Shu is a scholar working on Molecular Biology, Immunology, Hematology, Oncology and Epidemiology, having authored 35 papers that have together received 596 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (6 papers), Peroxisome Proliferator-Activated Receptors (6 papers), Acute Myeloid Leukemia Research (5 papers), Multiple Myeloma Research and Treatments (5 papers), Immune cells in cancer (4 papers), Diabetes and associated disorders (3 papers), Protein Degradation and Inhibitors (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). The work is most often cited by research in Cancer Research (125 citations), Hepatology (47 citations), Neurology (46 citations), Immunology (87 citations) and Molecular Biology (274 citations). Lingling Shu has collaborated with scholars based in China, Hong Kong and Czechia. Frequent co-authors include Aimin Xu, Ruby L.C. Hoo, Karen S.L. Lam, Xiaoping Wu, Boya Liao, Yong Pan, Weida Wang, Paul M. Vanhoutte, Siyuan He and Stefan R. Bornstein. Their work appears in journals such as Blood, Advanced Science, Cell Death and Disease, Nature Communications and Clinical Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.